Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.
2.

Leveraging graph topology and semantic context for pharmacovigilance through twitter-streams.

Eshleman R, Singh R.

BMC Bioinformatics. 2016 Oct 6;17(Suppl 13):335.

3.
4.

Correlating eligibility criteria generalizability and adverse events using Big Data for patients and clinical trials.

Sen A, Ryan PB, Goldstein A, Chakrabarti S, Wang S, Koski E, Weng C.

Ann N Y Acad Sci. 2017 Jan;1387(1):34-43. doi: 10.1111/nyas.13195. Epub 2016 Sep 6.

PMID:
27598694
5.

Are All Vaccines Created Equal? Using Electronic Health Records to Discover Vaccines Associated With Clinician-Coded Adverse Events.

Boland MR, Tatonetti NP.

AMIA Jt Summits Transl Sci Proc. 2015 Mar 23;2015:196-200. eCollection 2015.

6.
7.

Pediatric Drug Safety Surveillance in FDA-AERS: A Description of Adverse Events from GRiP Project.

de Bie S, Ferrajolo C, Straus SM, Verhamme KM, Bonhoeffer J, Wong IC, Sturkenboom MC; GRiP network..

PLoS One. 2015 Jun 19;10(6):e0130399. doi: 10.1371/journal.pone.0130399. eCollection 2015.

8.

Comedications alter drug-induced liver injury reporting frequency: Data mining in the WHO VigiBase™.

Suzuki A, Yuen NA, Ilic K, Miller RT, Reese MJ, Brown HR, Ambroso JI, Falls JG, Hunt CM.

Regul Toxicol Pharmacol. 2015 Aug;72(3):481-90. doi: 10.1016/j.yrtph.2015.05.004. Epub 2015 May 16. Erratum in: Regul Toxicol Pharmacol. 2015 Oct;73(1):348.

9.

Construction of a drug safety assurance information system based on clinical genotyping.

Springer JA, Iannotti NV, Sprague JE, Kane MD.

ISRN Bioinform. 2011 Nov 29;2012:982737. doi: 10.5402/2012/982737. eCollection 2012.

10.

Hypoglycemia in older people - a less well recognized risk factor for frailty.

Abdelhafiz AH, Rodríguez-Mañas L, Morley JE, Sinclair AJ.

Aging Dis. 2015 Mar 10;6(2):156-67. doi: 10.14336/AD.2014.0330. eCollection 2015 Mar. Review.

11.

Why are there deadly drugs?

Lexchin J.

BMC Med. 2015 Feb 5;13:27. doi: 10.1186/s12916-015-0270-2.

12.

FutureTox II: in vitro data and in silico models for predictive toxicology.

Knudsen TB, Keller DA, Sander M, Carney EW, Doerrer NG, Eaton DL, Fitzpatrick SC, Hastings KL, Mendrick DL, Tice RR, Watkins PB, Whelan M.

Toxicol Sci. 2015 Feb;143(2):256-67. doi: 10.1093/toxsci/kfu234.

13.

Lean Big Data integration in systems biology and systems pharmacology.

Ma'ayan A, Rouillard AD, Clark NR, Wang Z, Duan Q, Kou Y.

Trends Pharmacol Sci. 2014 Sep;35(9):450-60. doi: 10.1016/j.tips.2014.07.001. Epub 2014 Aug 7.

14.

Drug-induced liver injury in older adults.

Mitchell SJ, Hilmer SN.

Ther Adv Drug Saf. 2010 Dec;1(2):65-77. doi: 10.1177/2042098610386281. Review.

15.

Pharmacovigilance for psychiatrists: An introduction.

Rajkumar RP, Melvin G.

Indian J Psychiatry. 2014 Apr;56(2):176-81. doi: 10.4103/0019-5545.130502. No abstract available.

16.

Digital drug safety surveillance: monitoring pharmaceutical products in twitter.

Freifeld CC, Brownstein JS, Menone CM, Bao W, Filice R, Kass-Hout T, Dasgupta N.

Drug Saf. 2014 May;37(5):343-50. doi: 10.1007/s40264-014-0155-x. Erratum in: Drug Saf. 2014 Jul;37(7):555.

17.

Commonality of drug-associated adverse events detected by 4 commonly used data mining algorithms.

Sakaeda T, Kadoyama K, Minami K, Okuno Y.

Int J Med Sci. 2014 Mar 15;11(5):461-5. doi: 10.7150/ijms.7967. eCollection 2014.

18.
19.

International society for disease surveillance conference 2011: building the future of public health surveillance.

Neill DB, Soetebier KA.

Emerg Health Threats J. 2011 Dec 6;4:11702. doi: 10.3402/ehtj.v4i0.11702. No abstract available.

20.

Risk, reward, and the double-edged sword: perspectives on pharmacogenetic research and clinical testing among Alaska Native people.

Shaw JL, Robinson R, Starks H, Burke W, Dillard DA.

Am J Public Health. 2013 Dec;103(12):2220-5. doi: 10.2105/AJPH.2013.301596. Epub 2013 Oct 17.

Supplemental Content

Support Center